Liesbeth Deberdt

Liesbeth Deberdt is a Senior Clinical Study Leader and Associate Director at Galapagos, where they lead a cross-functional team managing phase 1 to 3 clinical studies in Immunology and Oncology. With 18 years of experience, Liesbeth has successfully overseen various clinical trials, including those in rare diseases and multiple therapeutic areas. Previously, they held roles at Terumo BCT and Eli Lilly, where they focused on project management and vendor oversight in clinical trials. Liesbeth holds a Master of Bioscience Engineering and an Academic Teaching Degree in Biology from Katholieke Universiteit Leuven.